Hikage, Makoto
Hato, Shinji
Uemura, Kohei
Yura, Masahiro
Sato, Yuya
Matsushita, Hisayuki
Cho, Haruhiko
Hiki, Naoki
Kunisaki, Chikara
Inoue, Kentaro
Choda, Yasuhiro
Boku, Narikazu
Yoshikawa, Takaki
Katai, Hitoshi
Terashima, Masanori http://orcid.org/0000-0002-2967-8267
Funding for this research was provided by:
National Cancer Center Research and Development Fund (26-A-4, 29-A-3, 2020-J-3)
Japan Agency for Medical Research and Developmen (JP18ck0106317)
Article History
Received: 12 July 2022
Accepted: 27 November 2022
First Online: 13 December 2022
Declarations
:
: Dr. Haruhiko Cho received personal fees from Ethicon, outside the submitted work. Dr. Naoki Hiki received grants and personal fees from Abbott Japan, EA, Johnson and Johnson, Otsuka, Kaken, Covidien Japan, Takeda, Daiichi Sankyo, Taiho, Tsumura, Terumo, MIYARISAN, grants from Shionogi, Chugai, HOGY medical, Yakult, personal fees from NHK, Pfizer, AstraZeneca, Nihon Pharma., Olympus, Novartis, Intuitive Surgical Japan, Ono, Kaigen, QLife, Sumitomo Dainippon, Nestlé Japan, outside the submitted work. Dr. Yasuhiro Choda received personal fees from Ono, Bristol-Myers Squibb, outside the submitted work. Dr. Narikazu Boku received personal fees from Taiho, Ono, Bristol-Myers Squibb, Daiichi Sankyo, outside the submitted work. Dr. Masanori Terashima received personal fees from Taiho, Chugai, Ono, Bristol-Myers Squibb, Yakult, Takeda, Eli Lilly, Pfizer, Daiichi Sankyo, Johnson and Johnson, Medtronic Japan, Intuitive Surgical Japan, Olympus, outside the submitted work. Drs. Makoto Hikage, Shinji Hato, Kohei Uemura, Masahiro Yura, Yuya Sato, Hisayuki Matsushita, Chikara Kunisaki, Kentaro Inoue, Takaki Yoshikawa, and Hitoshi Katai have no conflicts of interest or financial ties to disclose.